{"id":"W2945349403","doi":"10.1177/1758835919850367","title":"Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine <i>versus</i> FOLFIRINOX in advanced pancreatic cancer: a systematic review","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Health Services","funders":"Celgene","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Irinotecan; Internal medicine; Oxaliplatin; Neutropenia; Oncology; Pancreatic cancer; Gastroenterology; Cancer; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01426696,0.001409133,0.01205467,0.009164308,0.0006278528,0.003276662,0.001861783,0.001964331,0.003141375],"category_scores_gemma":[0.04192007,0.001150698,0.01025196,0.007999417,0.001157991,0.002234119,0.001371574,0.001127907,0.0002415658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004369635,"about_ca_system_score_gemma":0.009567787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005401736,"about_ca_topic_score_gemma":0.01704437,"domain_scores_codex":[0.9853314,0.006233406,0.005637722,0.0009156254,0.001590331,0.0002915497],"domain_scores_gemma":[0.9573556,0.02907362,0.009405251,0.0006425955,0.003030742,0.0004922958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007279234,0.0000197724,0.0008622037,0.9508228,0.03473044,0.00008476364,0.0001489136,0.00008068496,0.0002110082,0.00009942911,0.000362087,0.01184997],"study_design_scores_gemma":[0.001653826,0.0009031114,0.005633019,0.6579472,0.3240675,0.0003959038,0.0004102868,0.0001666445,0.0003344489,0.000270104,0.008161115,0.00005683988],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00515318,0.9926553,0.0002018873,0.0002565286,0.0001275721,0.0007944505,0.0004968122,0.00001208018,0.0003022049],"genre_scores_gemma":[0.09055014,0.903946,0.001695306,0.001046716,0.0001805622,0.001851741,0.0005171848,0.00001513279,0.0001971783],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01426696,"threshold_uncertainty_score":0.07545173,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1137865024179143,"score_gpt":0.5148520294269145,"score_spread":0.4010655270090003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}